Want to join the conversation?
$IDTI said its GAAP gross profit from continuing operations for 1Q17 was $108.3MM or 56.4% versus $99.2MM or 61.7% in 1Q16. GAAP R&D expense for 1Q17 was $49.6MM, compared to $33.8MM reported in the same period one year ago. GAAP SG&A expense was $38.8MM, compared to $28.1MM last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?